Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ganymed Pharmaceuticals AgfiledCriticalGanymed Pharmaceuticals Ag
Priority claimed from PCT/EP2003/002556external-prioritypatent/WO2003076631A2/en
Publication of MX340898BpublicationCriticalpatent/MX340898B/en
The invention relates to the identification of genetic products that are expressed in association with a tumor and the nucleic acid coding therefor. The invention relates to the therapy and diagnosis of diseases in which said genetic products that are expressed in association with a tumor are expressed in an aberrant manner. The invention also relates to proteins, polypeptides, and peptides which are expressed in association with a tumor and the nucleic acids coding therefor.
MX2011003661A2002-03-132003-03-12Genetic products differentially expressed in tumors and use thereof.
MX340898B
(en)